Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
The total study duration for each patient is approximatively 36 - 38 weeks broken down as follows:
* Screening period: up to 4 weeks,
* Treatment period: 24 weeks,
* Follow-up period: 10 weeks.
Age
55–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with diagnosis of Alzheimer's Disease (AD) (Cannot be dementia from strokes or other causes).
Patient is on stable and well-tolerated donepezil treatment at a dose of either 5 or 10 mg daily for at least 3 months prior to screening visit.
You may not be if
Age \<55 years old.
Psychotic features, agitation, or behavioral problems within the last 3 months.
Patients unable to comply with ophthalmologic monitoring.
Lack of consistent and reliable caregiver.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
